Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diabetes 2030: Insights from Yesterday, Today, and Future Trends.

Population health management·2016

Same author

Integrative medicine and health disparities: a scoping meeting.

Explore (New York, N.Y.)·2009

Same author

Disparities, cancer surveillance, and next steps.

Journal of cancer education : the official journal of the American Association for Cancer Education·2006

Same author

The future of patient-centered care: scenarios, visions, and audacious goals.

Journal of alternative and complementary medicine (New York, N.Y.)·2005

Same author

Drug regulation 2056.

Food and drug law journal·2005

Search research articles

Related Experiment Video

Updated: May 25, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Creating public awareness: state 2025 diabetes forecasts.

William R Rowley¹, Clement Bezold

¹Institute for Alternative Futures, Alexandria, Virginia 22314, USA. browley@altfutures.org

Population Health Management

|January 31, 2012

Summary

Diabetes prevalence is rising sharply, with significant increases projected. Early detection and lifestyle changes are crucial for prevention and managing diabetes complications.

Area of Science:

Public Health
Epidemiology
Health Economics

Background:

The incidence and prevalence of diabetes, particularly type 2 diabetes, have increased dramatically since 1990.
Projections indicate a 64% rise in diabetes cases between 2010 and 2025, impacting over 53 million individuals and incurring substantial economic costs.
While effective treatments and preventative measures exist, early detection of prediabetes and societal lifestyle changes are vital for reducing overall prevalence.

Purpose of the Study:

To enhance public awareness regarding the severity of regional diabetes trends.
To provide detailed state and metropolitan area forecasts for diabetes prevalence in 2010, 2015, and 2025.
To inform stakeholders about the potential impact and costs of diabetes at local levels for better decision-making and resource allocation.

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Related Experiment Videos

Last Updated: May 25, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Main Methods:

Development of a predictive model using the latest national diabetes and population data and projections.
Transformation of national data into state and metropolitan area forecasts for the general population and key demographic subgroups.
Summarization of forecasts into accessible briefing papers for public access online.

Main Results:

Detailed forecasts for diabetes prevalence and associated costs at state and metropolitan levels have been generated.
The study provides crucial data for understanding localized diabetes trends.
Accessible briefing papers facilitate informed decision-making for stakeholders.

Conclusions:

Addressing the escalating diabetes epidemic requires a comprehensive approach, including early detection, effective treatment, and significant societal lifestyle modifications.
The generated state and metro-level data are essential for targeted public health interventions and resource management.
Increased public awareness and data accessibility are key to mitigating the future impact of diabetes.